Your shopping cart is currently empty

OncoACP3 TFA (Compound s43) is a high-affinity ligand for prostatic acid phosphatase (ACP3). When labeled with Lu-177, OncoACP3 TFA selectively accumulates in tumors expressing the enzyme in HT1080.hACP3 and PC3.hACP3 xenograft mouse models, demonstrating significant antitumor activity and excellent tumor-selective payload deposition. OncoACP3 TFA is applicable to prostate cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | OncoACP3 TFA (Compound s43) is a high-affinity ligand for prostatic acid phosphatase (ACP3). When labeled with Lu-177, OncoACP3 TFA selectively accumulates in tumors expressing the enzyme in HT1080.hACP3 and PC3.hACP3 xenograft mouse models, demonstrating significant antitumor activity and excellent tumor-selective payload deposition. OncoACP3 TFA is applicable to prostate cancer research. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.